Lessons learned from a health authority research capacity-building initiative.


Journal

Healthcare management forum
ISSN: 0840-4704
Titre abrégé: Healthc Manage Forum
Pays: United States
ID NLM: 8805307

Informations de publication

Date de publication:
Sep 2019
Historique:
pubmed: 13 7 2019
medline: 14 7 2020
entrez: 13 7 2019
Statut: ppublish

Résumé

Health systems worldwide are under pressure to deliver better care to more people with increasingly complex needs within constrained budgets. Research capacity building has been shown to help alleviate these challenges and is underway at hospitals and health authorities across the country; however, approaches vary widely and little exists in the Canadian literature to share experience and best practices. This article describes how a health authority in British Columbia, Canada, implemented and evaluated a 5-year research capacity-building program in partnership with a provincial health research funder. We offer lessons learned for those leading similar innovation-focused change management initiatives, including vision and buy in, complexity thinking, infrastructure, leadership, and coalition development. We suggest that collective learning and building a more robust research capacity-building literature can help health organizations and their partners take significant steps toward integrating research and care for a more effective, efficient, and patient-centred health system.

Identifiants

pubmed: 31296028
doi: 10.1177/0840470419849468
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article

Langues

eng

Pagination

259-265

Auteurs

Cindy Trytten (C)

1 Research and Capacity Building Department, Island Health, Victoria, British Columbia, Canada.

Martin Wale (M)

2 Martin Wale Consulting, Victoria, British Columbia, Canada.

Michael Hayes (M)

3 University of Victoria, Victoria, British Columbia, Canada.

Bev Holmes (B)

4 Michael Smith Foundation for Health Research, Vancouver, British Columbia, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH